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Highly mutagenic heterocyclic aromatic
amines (HAAs) are formed during frying,
broiling, and barbecuing of meat (1-3).
Metabolic activation, involving N-hydrox-
ylation, is required for HAAs to exert their
genotoxic effects (4). Before adduction to
DNA nucleotides, many carcinogens
require metabolic activation to reactive
species (5). The N-hydroxy-metabolite of
the HAA 2-amino-3-methylimidazo[4,5-
fJquinoline (IQ) has been shown to bind
directly to DNA at physiological pH (6).
IQ is a potent carcinogen in rodents and
monkeys, inducing tumors at various sites
in rats and mice and hepatocellular carci-
nomas in cynomolgus monkeys (7-10).
DNA adducts are generally associated
with the initiation of the carcinogenic
process by HAAs, but less attention has
been given to their possible noncarcino-
genic effects. The discovery of high IQ-
DNA cardiac adducts by 3 P-postlabeling
analysis prompted us to undertake a histo-
logical study on hearts from tumor-bearing
monkeys chronically dosed with IQ (11).
Preliminary reports ofthis study have been
published in abstract form (12). The
myocardial abnormalities described here
closely resemble the early pathological
lesions associated with adriamycin (dox-
orubicin)-induced cardiotoxicity (13).
Doxorubicin is an anthracycline antibiotic
that binds to DNA and induces DNA
strand breaks,which have been shown to
correlate with its cytotoxic action (14-16).
Recent in vitro studies ofdoxorubicin ana-
logues have demonstrated that they com-
plex with DNA resulting in transcriptional
blockages (17). Considering that IQ has
been shown to covalently bind to DNA
(11) and induce DNA strand breaks in
mammalian cells (18), it is possible that
similar mechanisms are involved in the
induction ofmyocardial lesions by IQ and
doxorubicin.
Materials and Methods
The two monkey species used in this study
were Macacafascicularis (cynomolgus) and
Macaca mulatta (rhesus). They were born
in a closed monkey colony located at a
contract facility near the National Cancer
Institute. As newborns, they remained with
their mothers for the first 6 months, until
they were weaned. The diet consisted of
high protein Purina chow (5045 Stan-
dard), vitamin mixture spread on sand-
wiches, and apples (9). Dosing with IQ
was started at 1 year ofage. The monkeys
were housed individually in stainless-steel
cages in an AAALAC-accredited facility.
Ten tumor bearing monkeys used in
this histopathological study were part of a
larger carcinogenesis study (10). Theywere
dosed with IQ at 10 mg/kg or 20 mg/kg
five times per week for a period ranging
from 48 to 80 months (Table 1). Several of
the animals continued to receive IQ after a
tumor was diagnosed to observe other pos-
sible affects from IQ. IQwas suspended in
hydroxypropylcellulose (HPC) and admin-
istered by nasogastric intubation. The two
controls received only HPC. The monkeys
were euthanized with an overdose of pen-
tobarbital and the hearts were removed
immediately and fixed by retrograde perfu-
sion with a Trump-McDowell fixative
(4% formaldehyde, 1% glutaraldehyde)
for 60 min at 80-100 mm Hg. After the
pressure perfusion, 1-mm3 sections were
cut from the left (epicardial and endocar-
dial halves) and right ventricles, dehydrat-
ed in graded alcohol, and embedded in
epon for electron microscopy. One-
micron-thick-sections were cut from at
least three areas ofthe left ventricular epi-
cardial and endocardial halves and from
the right ventricle. Thin sections for elec-
tron microscopy were cut from at least
three areas of each sample, stained with
uranyl acetate and lead citrate, and exam-
ined with a Zeiss 109 microscope. The
remainder ofthe heart was cut transversely
from apex to base (five to six slices),
immersion-fixed overnight in 10% neutral
buffered formalin, and processed for light
microscopy. All ventricular slices were
embedded in paraffin, cut at 5 pm, and
stained with hematoxylin-eosin and Mas-
son trichrome.
Results
Before euthanasia, ECHO-cardiography
was carried out on the monkeys dosed
with IQ and the HPC treated controls.
None of the animals examined exhibited
cardiac abnormalities. We performed
histopathological analysis on perfusion-
fixed hearts from 10 monkeys chronically
dosed with IQ and two HPC controls. No
abnormalities were seen upon gross inspec-
tion ofthe hearts, and the heart weights of
all the animals were within normal limits
(Table 1). The average dosing period for
the group was 62.2 months (range 48-80
months), the average cumulative dose of
IQ was 53.53 g (range 24.58-91.10 g),
and the average cumulative dose/kg was
19.15 g (range 12.20-29.44 g; Table 1).
For two of the animals, there was correla-
tion between the dosing period and/or the
cumulative dose and the extent ofmyocar-
dial damage (Tables 1-3). For example,
the animal (case 1) with the highest cumu-
lative dose (91.10 g) had the largest variety
ofmyocardial lesions. Conversely, the ani-
mal (case 5) with the lowest cumulative
dose (24.58 g) and the shortest dosing
period (48 months) had normal myocardi-
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keys in this study (case 1) had numerous
primary tumor nodules and metastases
(pulmonary), the others had nonmetastatic
hepatocellular carcinoma with well-defined
tumor nodules ranging in numbers from
two to six. All the monkeys dosed with IQ
had one or more abnormal findings by
light microscopy, electron microscopy, or
both. The two control animals that re-
ceived only HPC, the vehicle for IQ, had
normal cardiac morphology.
We detected focal light microscopic
lesions in 8 of 10 hearts examined (Table
2). Multiple histological sections, stained
with hematoxylin and eosin or Masson
trichrome, were studied from each heart.
Table 1. Characteristics of monkeys studied for cardiac pathologic changes
Case Animal Birth IQ Dosing period Cumulative Cumulative Body Heart
no. no. Sex date (mg/kg) (months) dose (g) dose/kg (g) weight (kg) weight (g)
1 1423CC F 4/85 20 61 91.10 26.71 6.0 30.90
2 1427CC M 5/85 20 60 70.24 24.17 5.8 18.80
3 1433CC M 11/86 10 53 40.06 12.20 6.5 23.95
4 1393BB M 7/84 10 70 52.93 14.96 5.5 19.05
5 1428CC M 6/85 10 48 24.58 14.56 5.7 22.33
6 1398BB F 7/84 10 72 29.28 15.94 2.9 14.75
7 1430CC M 9/85 10 61 41.22 14.41 5.4 19.72
8 1454DD M 6/86 20 52 75.31 24.70 6.2 26.29
9 1432CC M 1/85 20 80 63.25 29.44 5.2 14.84
10 1447DD M 3/86 10 65 47.30 14.37 5.8 26.32
Controls
11 1487EE M 5/87
12 1464DD F 9/86
Table 2. Light microscope findings
Case no. Animal no. Fibrosis MN I/N MH Vasculitis
1 1423CC + + + - + +
2 1427CC - - + - + +
3 1433CC + + - +
4 1393BB - - - - -
5 1428CC - - - - -
6 1398BB - - - +
7 1430CC - + - - +
8 1454DD - - + + +
9 1432CC + + - - +
10 1447DD + + + + +
Controls
11 1487EE
12 1464DD
Abbreviations: MN, myocyte necrosis; I/N, inflammation associated with myocyte necrosis; 1, inflamma-
tion without myocyte necrosis; MH, myocyte hypertrophy.
Table 3. Electron microscopic findings
Case no. Animal no. Lipid ML MN MA
1 1423CC - + + +
2 1427CC + + + +
3 1433CC + - - +
4 1393BB - +
5 1428CC - +
6 1398BB -
7 1430CC - - - +
8 1454DD - + - +
9 1432CC - + + +
10 1447DD - + + +
Controls
11 1487EE -
12 1464DD -
Abbreviations: ML, myofibrillar loss; MN, myocyte necrosis; MA, mitochondrial abnormalities.
Scattered foci of interstitial fibrosis, with
myocyte hypertrophy and atrophy, were
present in the hearts from four animals
(cases 1, 3, 9, and 10; Fig. 1). The fibrosis
was most prominent in the subendocardi-
um. Five animals (cases 1, 3, 7, 9, and 10)
had single-cell myocyte necrosis. In four
animals (cases 1, 2, 8, and 10), myocyte
necrosis was associated with inflammation
(lymphocytes and macrophages), but
inflammation was also observed without
myocyte necrosis (cases 3, 6, 8, and 10),
especially adjacent to intramural arterioles
(Fig. 2). One heart (case 6) displayed occa-
sional small foci of interstitial chronic
inflammation without associated myocyte
necrosis or fibrosis. In two hearts (cases 1
and 2), the walls of scattered arterioles,
medium-sized muscular arteries, and veins
were infiltrated by mixed acute and chron-
ic inflammatory cells. The hearts from two
ofthe test animals (cases 4 and 5) and the
two control animals (cases 11 and 12), had
normal histology at the light microscopic
level.
We noted ultrastructural lesions in 9 of
10 hearts examined (Table 3). Examin-
ation of the myocardium revealed foci of
myofibrillar loss and disorganization ofthe
normal parallel alignment ofsarcomeres in
seven animals (cases 1, 2, 4, 5, 8, 9, and
10; Fig. 3A-C). In four of these animals
(cases 1, 2, 9 and 10), necrotic myocytes
were also present. Mitochondrial abnor-
malities were a frequent finding in seven of
the IQ hearts (cases 1, 2, 3, 7, 8, 9, and
10). These varied from mild to moderate
mitochondrial swelling, clearing of normal
matrix densities, and disruption of mito-
chondrial cristae (Fig. 3D and 4). Amor-
phous mitochondrial matrix densities were
seen in occasional myocytes in one case.
Nuclear changes were seen in occasional
cells and consisted of hypertrophy and
peripheral clumping of the nuclear chro-
matin. No capillary abnormalities were
noted, but increased collagen deposition
was present in the interstitium of the
subendocardium. In the two animals (cases
4 and 5) with no light microscopic abnor-
malities, the only electron microscopic
findings were myofibrillar loss. Normal
ultrastructural architecture was displayed
in one of the IQ animals (case 6) and in
the two HPC controls (cases 11 and 12;
Fig. 5).
Discussion
The present findings suggest that chronic
exposure to mutagenic dietary HAAs such
as IQ can result in myocardial damage in
nonhuman primates. The myocardial
lesions were focal and not associated with
ECHO-cardiographic abnormalities or evi-
dence of congestive heart failure. Light
microscopic lesions were detected in 80%
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um by light microscopy and the only elec-
tron microscopy finding was focal myofib-
rillar loss. For the other animals, the
cumulative dose correlated better than the
dosing period with the myocardial abnor-
malities. As stated above, all of the mon-
keys included in this study had malignant
liver tumors. Therefore, the myocardial
lesions could possibly be secondary to the
liver malignancies rather than IQ-mediated
damage. Although it cannot be categorical-
ly ruled out at this point, it is unlikely that
the liver tumors were responsible for the
myocardial lesions because the lesions did
not correlate with the number or size of
the tumor nodules. Only one of the mon-
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Figure 1. Light microscopic view of myocardial lesions in monkeys dosed with IQ. (A,B)-case 10: a focus
of myocyte loss with early replacement fibrosis and scattered chronic inflammatory cells in the left ven-
tricle. Myocyte hypertrophy is presentfocally in the surrounding myocardium (arrowheads). (CF-case 1:
myofibrillar loss in two myocytes (arrowheads) with adjacent myocytes showing nuclear hypertrophy
(arrows). (D)-case 10: focal fibrosis with extension into surrounding myocytes. (A) 240x and (C) 350x;
hematoxylin-eosin. (B) 240x and (D) 75x; Masson trichrome.
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Figure 2. Light microscopic view of inflammatory infiltrates, myocardium of monkeys
dosed with IQ. (A,B)-cases 10 and 8, respectively: focal collections ofchronic inflam-
matory cells lymphocytess and macrophages) with myocyte dropout in sections from
leftventricle. (A,B)320x; hematoxylin-eosin.
ofthe perfusion-fixed hearts examined and
ultrastructural abnormalities in 90% ofthe
cases. IQ-induced liver pathology has been
described elsewhere (9,10), but microscop-
ic evaluation ofother organs did not reveal
any histopathological findings.
The structural myocardial abnormali-
ties found in these macaques chronically
dosed with IQ included focal myocyte
necrosis, myocardial interstitial fibrosis,
myofibrillar loss, and mitochondrial dam-
age. These findings are consistent with the
initial stages of toxic cardiomyopathy. A
pathologic hallmark oftoxic cardiomyopa-
thy is the simultaneous presence oflesions
in various stages of evolution (20). For
example, acute myocyte necrosis, inflam-
mation, and myocyte dissolution are seen
concurrently with foci of interstitial fibro-
sis. In five ofthe monkeys dosed with IQ,
myocardial lesions of various stages of
development were present, suggestive of a
cardiotoxic process. Toxic myocarditis that
results in cardiomyopathy is a dose-depen-
dent process and can be expected to be
most severe in subjects exposed to the
highest dose ofthe toxic agent (20). There
was some correlation between the extent of
myocardial damage and the cumulative
dose in the monkeys that received the
highest and the lowest dose ofIQ, but the
length of exposure to IQ correlated less
favorably with the extent ofcardiotoxicity.
Why a dose-response relationship was not
more apparent is unknown, but with addi-
tional animals and additional dose ranges,
such a response may become more distinct.
Statistical analysis was not carried out
on the data because the number ofanimals
was small (six in the 10 mg/kg group and
four in the 20 mg/kg group), and the
myocardial lesions were focal and consid-
ered at the initial stages of cardiotoxicity.
All the monkeys studied had one or more
malignant liver tumor nodules, and one
animal had evidence of lung metastasis at
the time of autopsy. Although it can be
argued that the myocardial lesions ob-
served in the IQ monkeys may be sec-
ondary to the malignant liver tumors there
was no correlation between the number of
the liver tumor nodules or the diameters of
individual nodules and the extent of
myocardial abnormalities. Further evidence
that the myocardial lesions were not sec-
ondary to tumor formation comes from
studies in rats where IQ was shown to pro-
duce cardiotoxicity in cultured myocytes
and in vivo (21).
Various drugs and chemicals have been
associated with toxic cardiomyopathy,
including anthracycline antibiotics (doxoru-
bicin, daunomycin) (22-25), cyclophos-
phamide (26), azidothymidine (27,28),
chloroquine (29,30), alcohol (31), ampheta-
mines (32), cocaine (33,34), and cobalt
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(35). The pathogenesis of toxic cardiomy-
opathy varies among different noxious
agents. Cardiotoxic drugs and chemicals
may act directly on the myocyte and alter
myocyte protein synthesis, interfere with
mitochondrial function, and/or disrupt cell
membrane permeability. Alternatively, the
vascular supply ofthe heart may be the tar-
get of toxic agents; vasoactive compounds
such as norepinephrine and amphetamine
can cause arteriolar vasoconstriction and
capillary endothelial damage, resulting in
secondary myocyte ischemia and necrosis.
High-dose cyclophosphamide therapy has
been associated with microthrombi in
intramyocardial capillaries (26).
Figure 3. Electron micrographs from four different IQ hearts. (A) Focal dissolution of myocyte myofibrils
and disruption of sarcomeres; 14,400x. (B) Left ventricular myocyte with moderate myofibrillar loss;
11,000x. (C) Three myocytes cut in cross-section demonstrating varying degrees of moderate (arrow-
heads) to severe (arrows) myofibrillar loss; 17,462x. (D) Abnormal mitochondria demonstrating disruption
and dissolution ofcristae (arrows) and focal clearing of matrix(arrowheads); 17,400x.
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Figure 4. Electron micrograph of myocyte necrosis. Case 1: Low (A) (2700x) and high
(B) (30,000x) power micrograph of a necrotic myocyte demonstrating mitochondrial
flocculent densities in(B)(arrowheads).
Figure 5. Electron micrographs of hydroxypropyl-
cellulose controls. (A,B)-cases 11 and 12,
respectively: normal myocardial ultrastructure
with sarcomeres (arrows) separated by normal
mitochondria (arrowheads).(A) 7200x,(B) 18,000x.
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Perhaps the best-characterized example
of drug-related toxic cardiomyopathy is
anthracycline-induced cardiomyopathy
(22-24). The most striking pathologic fea-
tures seen in myocytes is that ofmitochon-
drial damage, vacuolar degeneration (swel-
ling of sarcoplasmic reticulum and T-
tubules), and myofibrillar dissolution
(20,23). The mechanism of anthracycline-
induced cardiomyopathy is uncertain, but
may primarily involve direct toxic damage
ofmitochondria. In ultrastructural studies,
mitochondrial swelling, clearing ofnormal
matrix densities, mitochondrial cristae dis-
ruption, and mitochondrial degeneration
have been described (19). As a result of
mitochondrial dysfunction, impaired
oxidative phosphorylation may precipitate
loss ofenergy-requiring membrane perme-
ability function. Thus, explosive swelling
ofsarcoplasmic reticulum may be the con-
sequence of abnormal permeability. Ad-
ditionally, anthracyclines may be directly
toxic to myofilaments. The effectiveness of
anthracyclines as chemotherapeutic agents
is related to their ability to react with
DNA. The principal action ofdoxorubicin
is DNA strand breakage (36). We are not
aware of any studies where covalent bind-
ing ofdoxorubicin to myocardial DNA has
been assessed. However, the anthracycline
cyanomorpholino doxorubicin (MRA-CN)
has been shown to form adducts and cross-
links with DNA in vitro, and it has been
suggested that adducts to a single strand of
DNA precede the formation of the inter-
strand cross-links by MRA-CN (14).
Sequence-specific complexes of MRA-CN
with DNA have also been observed as
blocked transcripts in an in vitro transcrip-
tion assay (17). In comparison to IQ-
induced DNA adducts, the possibility
must be considered that cardiotoxic an-
thracyclines may act in the nucleus and
interfere with DNA transcription, resulting
in impairment of protein synthesis neces-
sary for the turnover of contractile and
membrane-bound proteins.
Anthracycline-induced cardiotoxicity
has been studied in a variety of animal
models, including rabbits, rats, mice, pigs,
dogs, and monkeys (37,38). The light
microscopic and ultrastructural cardiac
findings in the monkeys dosed with IQare
similar to those described for anthracy-
clines, including myocyte degeneration,
focal interstitial fibrosis, myofibrillar loss,
swelling of mitochondria, and clearing of
normal matrix densities. However, none of
these findings is specific for drug-induced
cardiomyopathy, nor do they indicate the
precise mechanism of potential myocyte
damage by IQ. An active metabolite ofIQ,
N-hydroxy-IQ, and its reactive esters,
including N-acetoxy-IQ, are known to
form adducts with DNA, and high levels
of IQ-DNA adducts have been observed
in the myocardium ofmonkeys chronically
dosed with IQ(11). Further studies to ana-
lyze the possible role of IQ-DNA adducts
in the etiology of the IQ-associated car-
diotoxicity are warranted. One can specu-
late that a potential mechanism of the IQ
toxicity to myocytes may be interference
with protein synthesis essential for the
maintenance of normal contractile ele-
ments. Alternatively, the abnormalities
seen in the mitochondria may suggest
interference with the transcription ofmito-
chondrial DNA, resulting in impairment
of mitochondrial protein synthesis and/or
oxidative phosphorylation. There is evi-
dence that IQ forms adducts with mito-
chondrial DNA in rat myocardium (21). It
will be important to find out if IQ-DNA
adducts are present in the mitochondria of
the monkey myocardium and if they are
responsible for the mitochondrial damage
observed in the majority ofthe IQcases.
This report describes the pathological
findings consistent with cardiotoxic effects
in nonhuman primates after chronic IQ
exposure. The myocardial lesions were
focal and none ofthe animals had evidence
of overt heart failure. It is possible that a
more prolonged exposure to IQ may be
necessary before clinical evidence ofcardiac
dysfunction occurs. However, one must
now consider the possibility that in addi-
tion to being carcinogenic, IQ and other
heterocyclic aromatic amines may produce
adverse effects on the cardiovascular sys-
tem. Further studies to quantify the role
that heterocyclic aromatic amines may play
in the etiology of cardiovascular diseases
are in progress.
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